Clinical Trial Update: Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers [Phase 3]

View source ↗

Summary

Long-term follow-up results from the DEVO pivotal Phase 3 trial evaluating Dermagraft for venous leg ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer

Drugs mentioned

• Dermagraft (human fibroblast-derived dermal substitute)

Snippet

Sponsor: Shire Regenerative Medicine, Inc. | Conditions: Venous Leg Ulcer | Phase 3 | Status: COMPLETED